Bowie, MD, United States of America

Jacqueline Smith


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Jacqueline Smith in Cancer Treatment

Introduction

Jacqueline Smith, an accomplished inventor based in Bowie, MD, has made significant contributions to the field of medical science through her innovative patents. With a total of three patents to her name, she focuses on developing targeted therapies for serious health conditions, particularly cancer.

Latest Patents

Jacqueline's latest patents showcase her innovative approach to treating various forms of cancer. One of her notable inventions is a patent for "Small molecule inhibitors of XBP1 splicing," which includes methods for treating or preventing cancer, particularly endocrine-resistant breast cancer, diabetes, and obesity. Additionally, she has developed a patent for a "Glutathione-cleavable prodrug and methods of use thereof," designed for treating cancer, including triple-negative breast cancer. This prodrug can be activated by glutathione under physiological conditions, making it advantageous as it is fluorescent, allowing for real-time monitoring in subjects.

Career Highlights

Jacqueline Smith works at Georgetown University, where her research and innovation are essential in advancing medical therapies. Her career is marked by a dedicated commitment to finding solutions for challenging medical issues through her inventions.

Collaborations

In her professional journey, Jacqueline collaborates with esteemed colleagues such as Milton L. Brown and Sivanesan Dakshanamurthy. These partnerships enhance her ability to drive research forward, leading to groundbreaking discoveries that can potentially change patient outcomes.

Conclusion

Jacqueline Smith exemplifies the spirit of innovation, paving the way for new treatments in cancer care. Her contributions, particularly in developing small molecule inhibitors and prodrugs, highlight her dedication to improving the lives of patients suffering from complex diseases. As her career continues, the impact of her work is likely to resonate within both the scientific community and the wider healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…